Somatic mutations of JAK2 exon 12 in patients with JAK2 (V617F)-negative myeloproliferative disorders.

Blood 2008 Feb 5;111(3):1686-9. Epub 2007 Nov 5.

Department of Hematology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo and University of Pavia, Pavia, Italy.

We searched for JAK2 exon 12 mutations in patients with JAK2 (V617F)-negative myeloproliferative disorders. Seventeen patients with polycythemia vera (PV), including 15 sporadic cases and 2 familial cases, carried deletions or duplications of exon 12 in circulating granulocytes but not in T lymphocytes. Two of the 8 mutations detected were novel, and the most frequent ones were N542-E543del and E543-D544del. Most patients with PV carrying an exon 12 mutation had isolated erythrocytosis at clinical onset, unlike patients with JAK2 (V617F)-positive PV, most of whom had also elevations in white blood cell and/or platelet counts. Both patients with familial PV carrying an exon 12 mutation had an affected sibling with JAK2 (V617F)-positive PV. Thus, several somatic mutations of JAK2 exon 12 can be found in a myeloproliferative disorder that is mainly characterized by erythrocytosis. Moreover, a genetic predisposition to acquisition of different JAK2 mutations is inherited in families with myeloproliferative disorders.

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2007-07-101576DOI Listing
February 2008
13 Reads

Publication Analysis

Top Keywords

patients jak2
12
jak2 exon
12
myeloproliferative disorders
12
exon mutation
8
v617f-negative myeloproliferative
8
carrying exon
8
mutations jak2
8
jak2 v617f-negative
8
somatic mutations
8
jak2
8
jak2 v617f-positive
8
patients
6
exon
6
clinical onset
4
onset patients
4
white blood
4
cell and/or
4
blood cell
4
erythrocytosis clinical
4
elevations white
4

Similar Publications